• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Oric Pharmaceuticals, Inc. - Common Stock (NQ:ORIC)

    10.47 -0.60 (-5.42%)
    Streaming Delayed Price Updated: 1:34 PM EDT, Aug 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 959,893
    Open 11.33
    Bid (Size) 10.47 (400)
    Ask (Size) 10.49 (300)
    Prev. Close 11.07
    Today's Range 10.45 - 11.45
    52wk Range 7.230 - 14.93
    Shares Outstanding 54,532,614
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
    From ORIC Pharmaceuticals
    Via GlobeNewswire

    Performance

    YTD
    +28.2%
    +28.2%
    1 Month
    -4.0%
    -4.0%
    3 Month
    +8.7%
    +8.7%
    6 Month
    -6.2%
    -6.2%
    1 Year
    +7.4%
    +7.4%

    More News

    Read More
    News headline image
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ORIC Investors Have Opportunity to Join ORIC Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc. - ORIC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ORIC Investors Have Opportunity to Join ORIC Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2026-04-01: top gainers and losers in today's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    What's Behind The Drop In Oric Pharmaceuticals Stock Today? ↗
    Via Benzinga
    These stocks are gapping in today's session ↗
    Via Chartmill
    Which stocks are moving before the opening bell on Wednesday? ↗
    Via Chartmill
    Top movers in Tuesday's after hours session ↗
    Via Chartmill
    News headline image
    ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Disease Profile
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗
    Via The Motley Fool
    News headline image
    Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Oric Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Oric Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Oric Pharmaceuticals, Inc. - Common Stock trade on?
    Oric Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Oric Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Oric Pharmaceuticals, Inc. - Common Stock is ORIC on the Nasdaq Stock Market
    What is the current price of Oric Pharmaceuticals, Inc. - Common Stock?
    The current price of Oric Pharmaceuticals, Inc. - Common Stock is 10.47
    When was Oric Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Oric Pharmaceuticals, Inc. - Common Stock was at 08/03/26 01:34 PM ET
    What is the market capitalization of Oric Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Oric Pharmaceuticals, Inc. - Common Stock is 570.96M
    How many shares of Oric Pharmaceuticals, Inc. - Common Stock are outstanding?
    Oric Pharmaceuticals, Inc. - Common Stock has 571M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.